Paper Details
- Home
- Paper Details
Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Author: ChernerJ A, CollenM J, GardnerJ D, HowardJ M, JensenR T, MatonP N, McArthurK E
Original Abstract of the Article :
The H2-histamine receptor antagonists ranitidine and cimetidine were compared for their abilities to control gastric acid hypersecretion on a short- and long-term basis in 22 patients with gastric acid hypersecretory states. Nineteen patients had Zollinger-Ellison syndrome, one patient had systemic ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/6150641
データ提供:米国国立医学図書館(NLM)
H2-Histamine Receptor Antagonists: A Comparison of Ranitidine and Cimetidine
The world of gastrointestinal health is a delicate balance, often disrupted by conditions like gastric hypersecretion. This study, like a camel traversing the desert, seeks to compare the effectiveness of two H2-histamine receptor antagonists, ranitidine and cimetidine, in treating this condition.
The researchers, guided by the principles of clinical trials, evaluated the effectiveness of both drugs in controlling gastric acid secretion in patients with gastric hypersecretory states. They meticulously monitored the response to these drugs, seeking to determine their relative efficacy and safety.
Ranitidine Emerges as the More Potent Choice: A Superior Oasis in the Desert of Gastrointestinal Issues
The study findings, like a well-charted oasis in the desert, reveal that ranitidine is significantly more potent than cimetidine in inhibiting gastric acid secretion. It achieved similar levels of acid control with a much lower dosage, offering a more efficient and potentially safer approach to treating gastric hypersecretion.
A Better Option for Patients: A Path Towards Relief
This study, like a beacon in the desert, highlights the importance of careful consideration when choosing an H2-histamine receptor antagonist. The findings suggest that ranitidine, with its superior potency and lower side effects, may be a more desirable option for many patients suffering from gastric hypersecretion.
Dr. Camel's Conclusion
This study, like a journey through the desert, reveals the importance of carefully considering different treatment options for gastric hypersecretion. The findings suggest that ranitidine, with its superior potency and reduced side effects, may offer a more efficient and potentially safer approach compared to cimetidine. This research, like a well-worn path in the desert, guides us towards a more effective and personalized approach to managing this common gastrointestinal condition.
Date :
- Date Completed 1985-01-03
- Date Revised 2018-11-30
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.